Stay updated on MEK162 vs Dacarbazine in NRAS+ Melanoma Clinical Trial

Sign up to get notified when there's something new on the MEK162 vs Dacarbazine in NRAS+ Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MEK162 vs Dacarbazine in NRAS+ Melanoma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision: v3.3.2 added to the page history, replacing v3.2.0 and reflecting a platform/UI update rather than changes to study data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T14:45:06.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The page no longer displays a government funding and operating status notice that appeared at the top; this change does not affect the study record or its data.
    Difference
    0.5%
    Check dated 2025-11-18T07:27:32.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    The old and new screenshots show minor UI/layout adjustments on the Record History page, while the version list and navigation remain unchanged. There is no change to core study data, status, or substantive content.
    Difference
    0.1%
    Check dated 2025-11-03T21:33:23.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    Added a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.
    Difference
    10%
    Check dated 2025-10-06T07:16:24.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.2%
    Check dated 2025-09-29T03:47:03.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2, and the Back to Top link was removed. No substantive updates to core content or pricing.
    Difference
    0.6%
    Check dated 2025-09-14T21:36:41.000Z thumbnail image

Stay in the know with updates to MEK162 vs Dacarbazine in NRAS+ Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MEK162 vs Dacarbazine in NRAS+ Melanoma Clinical Trial page.